Epigenomics Receives FDA Approval for Colorectal Cancer Screening Test
The first blood-based screening test for colorectal cancer will be made available in the United States under a joint commercialization agreement with Polymedco.
Read MorePosted by Elaine Sanchez Wilson | Apr 19, 2016 | Cancer, Colorectal, Unknown Origin & Other Cancer Types |
The first blood-based screening test for colorectal cancer will be made available in the United States under a joint commercialization agreement with Polymedco.
Read MorePosted by Elaine Sanchez Wilson | Apr 14, 2016 | Coagulation Testing, Hematology & Serology, POC Instruments, Urinalysis & Toxicology |
Urinalysis instruments offer expanding feature sets designed to meet diverse testing requirements.
Read MorePosted by Elaine Sanchez Wilson | Apr 11, 2016 | Emerging & Zoonotic Diseases, Infectious Diseases |
An international partnership is working to validate a multiplex qualitative nucleic acid assay that simultaneously tests for a broad array of the most common mosquito-borne disease agents.
Read MorePosted by Elaine Sanchez Wilson | Apr 11, 2016 | Cancer, Lung Cancer, Molecular Diagnostics, Research |
Study demonstrates the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting specific mutations.
Read MorePosted by Elaine Sanchez Wilson | Apr 1, 2016 | Cancer, Molecular Diagnostics |
A history-weighting algorithm has been shown to upgrade and downgrade variants of uncertain significance to more definitive clinical classifications, with high accuracy.
Read More